EP1968594
Meðhöndlun á augnnýæðamyndunarröskunum svo sem augnbotnahrörnun, hornhimnuæðarákum, lithimnubólgu og blettabjúg.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
29.11.2006EP published:
29.9.2010EP application number:
06838635.8
EP translation filed:
22.11.2010Grant published:
15.12.2010EPO information:
European Patent Register
Max expiry date:
28.11.2026Expiry date:
29.11.2014
Title:
TREATMENT OF OCULAR NEOVASCULAR DISORDERS SUCH AS MACULAR DEGENERATION, ANGIOD STREAKS, UVEITIS AND MACULAR EDEMA
Timeline
Today
29.11.2006EP application
29.9.2010EP Publication
22.11.2010Translation submitted
15.12.2010Registration published
29.11.2014Expires
Owner
Name:
GlaxoSmithKline LLCAddress:
One Franklin Plaza 200 North 16th Street, 19102, Philadelphia, PA, US
Inventor
Name:
BRIGANDI, Richard AnthonyAddress:
Collegeville, PA, US
Name:
LEVICK, MarkAddress:
Collegeville, PA, US
Name:
MILLER, William HenryAddress:
Collegeville, PA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
740478 PDate:
29.11.2005Country:
US
Classification
Categories:
A61K 31/506, A61P 27/02, A61K 31/55
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 26.10.2010
Expires: 29.11.2011
Payer: Örn Þór, slf.
Number: 6
Paid: 20.10.2011
Expires: 29.11.2012
Payer: Örn Þór, slf.
Number: 7
Paid: 18.10.2012
Expires: 29.11.2013
Payer: Örn Þór, slf.
Number: 8
Paid: 14.10.2013
Expires: 29.11.2014
Payer: Örn Þór, slf.